APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S, Li Y, Xu J, Shen L, et al. Neurol Res 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao S, Li Y, Xu J, Shen L, et al. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Neurol Res 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
PMID: 38007705